Zimmer Biomet initiated a field action for sterile-packaged implants packaged in two different package configurations due to packaging design verification test failures. Zimmer Biomet sent letters via Fed-Ex and e-mail dated 02/28/2017 to customers informing them of the recall, and instructing them to do the following:
1. Review this notification and ensure affected team members are aware of the contents.
2. Complete the Certification of Acknowledgement portion of Attachment 1
a. Return a digital copy to
[email protected] within three
(3) days.
3. Assist the Zimmer Biomet sales representative quarantine all affected product.
4. If after reviewing this notice customers have further questions or concerns, please call 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday. Calls received outside of the call center operating hours will receive a prompt to record a voicemail or be transferred to an oncall representative in the case of an emergency. Alternatively, questions may be sent by
email to
[email protected].
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA:
MedWatch Reporting: Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by mail, or by fax.
Online: www.fda.gov/medwatch/report.htm
Mail: Use postage paid, pre-addressed form FDA 3500, available at: www.fda.gov/MedWatch/getforms.htm
Fax: 1-800-FDA-0178
Under 21 CFR 803, manufacturers are required to report any serious injuries where a product has contributed or may have contributed to the event. Please keep Zimmer Biomet informed of any adverse events associated with this product or any other Zimmer Biomet product by emailing
[email protected].
For questions regarding this recall call 574-371-3071.